Pharmaceutical

mRNA licensing agreements surge 800% amid GSK lawsuits

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are facing lawsuits.

Oct 20, 2024 - 04:00
mRNA licensing agreements surge 800% amid GSK lawsuits
An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are facing lawsuits.
Read the original article

Tags:

Previous Article

Avadel wins FDA approval for narcolepsy drug Lumryz in children

Next Article

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

US FDA approves Merck’s Ebola vaccine for under-18s

US FDA approves Merck’s Ebola vaccine for under-18s

Aug 4, 2023

STAT+: With weight loss drug ads, telehealth companies wade into a regulatory gray area

STAT+: With weight loss drug ads, telehealth companies ...

Apr 7, 2023

STAT+: Teva sues Colorado over ‘unconstitutional’ program to lower cost of epinephrine injectors

STAT+: Teva sues Colorado over ‘unconstitutional’ progr...

Oct 16, 2023